FROM Michael de la Merced
Alibaba’s Wooing of Wall Street Fifteen years ago, Jack Ma—the founder of China’s Alibaba—was laughed out of Wall Street. Now the world’s biggest investors are clamoring for a piece of what could be the biggest IPO ever. On Monday, Alibaba held the first of 100 meetings in 10 days, selling itself to potential investors for the first time. It all started in New York City, where 800 people piled into three big rooms at the Waldorf Astoria. One of those in the crowd was Michael de la Merced, reporter for DealBook , a financial news service for the New York Times.
Finger Pointing Follows Facebook's IPO Fiasco Shares of Facebook we initially priced at $38 a share. On the second day of trading, shares tumbled by as much as 18 percent. Fingers of blame are being pointed at Morgan Stanly, Nasdaq and even at Facebook itself. What went wrong with the most highly anticipated high-tech debut in years? Michael de la Merced reports for the Dealbook Section of the New York Times .
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.
Venezuela spirals into economic and political chaos Venezuela, a country whose potential for prosperity is unmatched, finds itself on the verge of civil war. What sustains the repressive government? With time running out, guest host León Krauze looks at what the international community can do to pull the country from the edge of collapse.
Terrorism and tweets, hate speech and murder Just days before an election, Britain is coping with a rash of deadly terrorism, and Prime Minister Theresa May is on the defensive. And again today, President Trump has tweeted criticism of the Mayor of London. Later, a double murder in Portland, Oregon has revealed the ugly past of a supposedly “progressive” city. One immediate question: is “hate speech” protected by the First Amendment?
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?